Table 4.

Participant-specific analysis of response by intervention arm based on agent compliance

Compliance statusParticipant-level responsemyo-Inositol (N = 38)Placebo (N = 35)Pa
Compliantbn = 25n = 28
PD12 (48.0%)9 (32.1%)0.73
SD or PR7 (28.0%)16 (57.2%)
CR6 (24.0%)3 (10.7%)
Noncompliantbn = 13n = 7
PD6 (46.2%)3 (37.5%)0.91
SD or PR3 (23.1%)3 (37.5%)
CR4 (30.8%)2 (25.0%)
  • aKruskal–Wallis test.

  • bDefined as the number of sachets taken by the participant divided by the number of sachets that should have been taken by the participant based on a 6-month intervention.